Edmp, Inc. Astrazeneca PLC Transaction History

Edmp, Inc.

$109 Million
Q2 2024

A detailed history of Edmp, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Edmp, Inc. holds 20,140 shares of AZN stock, worth $1.56 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

20,140

Previous 20,140 -0.0%

Holding current value

$1.56 Million

Previous $1.36 Million 15.1%

% of portfolio

1.44%

Previous 1.18%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$61.03 - $69.57 $37,899 - $43,202	-621 Reduced 2.99%	20,140 $1.36 Million
Q4 2023 Jan 25, 2024	SELL	$61.89 - $69.28 $26,488 - $29,651	-428 Reduced 2.02%	20,761 $1.4 Million
Q3 2023 Oct 23, 2023	SELL	$64.85 - $71.7 $88,649 - $98,013	-1,367 Reduced 6.06%	21,189 $1.43 Million
Q2 2023 Jul 24, 2023	SELL	$69.91 - $75.81 $3,984 - $4,321	-57 Reduced 0.25%	22,556 $1.61 Million
Q1 2023 Apr 20, 2023	SELL	$63.15 - $71.6 $72,811 - $82,554	-1,153 Reduced 4.85%	22,613 $1.57 Million
Q4 2022 Feb 06, 2023	SELL	$54.21 - $70.44 $86.1 Million - $112 Million	-1,588,052 Reduced 98.53%	23,766 $1.61 Million
Q4 2022 Feb 01, 2023	BUY	$54.21 - $70.44 $86 Million - $112 Million	1,587,325 Added 6480.73%	1,611,818 $109 Million
Q3 2022 Oct 20, 2022	SELL	$53.02 - $135.75 $29,107 - $74,526	-549 Reduced 2.19%	24,493 $1.34 Million
Q2 2022 Jul 28, 2022	SELL	$59.26 - $71.14 $9,126 - $10,955	-154 Reduced 0.61%	25,042 $1.66 Million
Q1 2022 Apr 28, 2022	SELL	$55.72 - $67.12 $15,935 - $19,196	-286 Reduced 1.12%	25,196 $1.67 Million
Q4 2021 Jan 19, 2022	SELL	$54.02 - $63.83 $111,119 - $131,298	-2,057 Reduced 7.47%	25,482 $1.48 Million
Q3 2021 Oct 20, 2021	BUY	$55.56 - $60.79 $1.53 Million - $1.67 Million	27,539 New	27,539 $1.65 Million

Others Institutions Holding AZN

# of Institutions

1,333

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edmp, Inc. with notifications on news.

Account